Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

Lonn EM, Yusuf S, Jha P, Montague TJ, Teo KK, Benedict CR, Pitt B.

Circulation. 1994 Oct;90(4):2056-69. Review. No abstract available.

PMID:
7923694
2.

Expanding the paradigm of the renin-angiotensin system and angiotensin-converting enzyme inhibitors.

Greenwald L, Becker RC.

Am Heart J. 1994 Nov;128(5):997-1009. Review.

PMID:
7942494
3.

Role of angiotensin-converting enzyme inhibitors in the coronary artery bypass patient.

Lazar HL.

Ann Thorac Surg. 2005 Mar;79(3):1081-9. Review.

PMID:
15734453
4.

[Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].

Ceconi C, Mastrorilli F, Squasi PA, Gaitani S, Guardigli G, Ferrari R.

Ital Heart J. 2005 Nov;6 Suppl 7:5S-13S. Review. Italian.

PMID:
16485512
5.

Anti-ischemic potential of drugs related to the renin-angiotensin system.

Ertl G, Hu K.

J Cardiovasc Pharmacol. 2001 Apr;37 Suppl 1:S11-20. Review.

PMID:
11392474
6.

Role of bradykinin in the antihypertensive and cardioprotective actions of converting enzyme inhibitors.

Zhu YC, Stauss HM, Bao G, Gohlke P, Zhu YZ, Redlich T, Unger T.

Can J Physiol Pharmacol. 1995 Jul;73(7):827-31. Review.

PMID:
8846416
7.

Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins.

Tschöpe C, Gohlke P, Zhu YZ, Linz W, Schölkens B, Unger T.

J Card Fail. 1997 Jun;3(2):133-48. Review.

PMID:
9220313
8.

[Suppression of angiotensin-converting enzyme and myocardial ischemia].

Eliseev OM.

Ter Arkh. 1999;71(3):73-6. Review. Russian. No abstract available.

PMID:
10234773
9.

Zofenopril in cardiac surgery.

Tammam Y.

Pediatr Med Chir. 2007 Jan-Feb;29(1):23-7. Review.

PMID:
17557506
10.

STOPPING at the CAPPP of good HOPE.

Luft FC.

Nephrol Dial Transplant. 2000 Apr;15(4):451-2. Review. No abstract available.

PMID:
10727535
11.

Kinins and the vascular actions of converting enzyme inhibitors.

Mombouli JV, Vanhoutte PM.

Curr Opin Nephrol Hypertens. 1994 Sep;3(5):481-4. Review. No abstract available.

PMID:
7804745
12.

[Anti-ischemic and infarction-reducing effects of angiotensin-converting enzyme inhibitors].

Landmark K, Aursnes I.

Tidsskr Nor Laegeforen. 2001 Jun 20;121(16):1923-6. Review. Norwegian.

PMID:
11488184
13.

Prevention of cardiovascular ischemic events: high-risk and secondary prevention.

Genest J, Pedersen TR.

Circulation. 2003 Apr 22;107(15):2059-65. Review. No abstract available.

15.

Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors.

Juggi JS, Koenig-Berard E, Van Gilst WH.

Can J Cardiol. 1993 May;9(4):336-52. Review.

PMID:
8513428
16.

Early use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: evidence from clinical trials.

Moukarbel GV, Solomon SD.

Curr Heart Fail Rep. 2008 Dec;5(4):197-203. Review.

PMID:
19032914
17.

Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure?

Cleland JG, John J, Houghton T.

Curr Opin Nephrol Hypertens. 2001 Sep;10(5):625-31. Review.

PMID:
11496056
18.

Emerging role of ACE inhibitors in prevention of myocardial infarction and unstable angina.

Krishnamoorthy KM.

Indian Heart J. 1999 Mar-Apr;51(2):218-22. Review. No abstract available.

PMID:
10407557
19.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis.

Lonn E.

Curr Atheroscler Rep. 2002 Sep;4(5):363-72. Review.

PMID:
12162936
20.

Summary of randomized trials of angiotensin converting enzyme inhibitors.

Yusuf S, Lonn E, Bosch J, Gerstein H.

Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):835-45. Review.

PMID:
10423106

Supplemental Content

Support Center